Goodwill - Additional Information (Detail) |
12 Months Ended | ||||
---|---|---|---|---|---|
Jul. 12, 2017
USD ($)
|
Sep. 30, 2015
USD ($)
|
Nov. 30, 2017
USD ($)
$ / Unit
|
Nov. 30, 2016
USD ($)
|
Aug. 31, 2016
USD ($)
|
|
Goodwill [Line Items] | |||||
Note payable to seller | $ 7,500,100 | $ 10,150,100 | |||
Royalty expense | 112,830 | ||||
Goodwill impairment charge | 111,392 | $ 1,666,430 | |||
Goodwill | 0 | $ 0 | |||
Asset Purchase Agreement [Member] | |||||
Goodwill [Line Items] | |||||
Asset Purchase Agreement, purchase price less cash and prepaids | 2,400,000 | ||||
Asset Purchase Agreement, cash and inventory paid | 1,553,272 | ||||
Note payable to seller | $ 1,300,000 | ||||
Royalty payment per bag set unit sold | $ / Unit | 5 | ||||
Royalty expense | $ 100,000 | ||||
Remaining Future Royalty Payments | $ 0 | ||||
Asset Purchase Agreement [Member] | Minimum [Member] | |||||
Goodwill [Line Items] | |||||
Royalty expense | 35,000 | ||||
Asset Purchase Agreement [Member] | CytoMedical [Member] | |||||
Goodwill [Line Items] | |||||
Asset Purchase Agreement, cash paid | $ 586,675 | $ 966,597 |
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer, less cash outflow and prepaid expense paid to seller by purchaser. No definition available.
|
X | ||||||||||
- Definition Business combination recognized identifiable assets acquired and liabilities assumed cash and inventory. No definition available.
|
X | ||||||||||
- Definition Royalty or license fees payable. No definition available.
|
X | ||||||||||
- Definition Royalty payment per unit. No definition available.
|
X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|